Modifiable cardiovascular risk factors linked to severity of COVID-19
Jun 16, 2021
Strategies that improve cardiovascular health also may improve outcomes for people following COVID-19.
Model estimates mortality risk in adults with dementia
Oct 14, 2022
A mortality prediction may help guide treatment and advance care planning for community-dwelling older adults with dementia.
ACC offers guidance on cardiovascular sequelae of COVID-19
Mar 18, 2022
The guidelines address myocarditis and other types of myocardial involvement, postacute sequelae of SARS-CoV-2 and return to exercise.
Poor oral health tied to greater severity of COVID-19
Oct 14, 2021
A subgroup analysis suggests that poor oral health may increase the severity of COVID-19 in patients with cardiovascular diseases.
Small CV impact seen when replacing salt with low-sodium salt substitute
Aug 24, 2022
The small effects of LSSS versus regular salt on cardiovascular health in adults may be important when implemented at the population level
US surgeon general announces national plan to fight ‘loneliness epidemic’
May 02, 2023
Loneliness can lead to pain, depression and shorter life spans in older adults and can impact sleep, inflammation and the immune system in younger adults.
Muscle strengthening may cut risk for noncommunicable disease
Mar 01, 2022
Muscle-strengthening activities were inversely linked to risks for all-cause mortality and major noncommunicable diseases.
Tech can help measure paces for seniors with heart issues, but doesn’t supply the final step: long-term...
By
Aaron Dorman
Sep 28, 2023
New studies indicate devices can help residents stay fit and avoid heart emergencies, but motivation may need to come from caregivers.
High coffee intake linked to CVD mortality in severe hypertension
Dec 21, 2022
“These findings may support the assertion that people with severe high blood pressure should avoid drinking excessive coffee,” a coauthor said in a statement.
For many, myocarditis risk higher after SARS-CoV-2 infection than vaccination
Aug 23, 2022
But the myocarditis risk was higher after vaccination for men younger than age 40 years, particularly after the second dose of mRNA-1273.